CUEDC2 and acute myeloid leukemia: Our data supported CUEDC2 as a tumour suppressor because we found that overexpression of CUEDC2 inhibited AML cell proliferation, caused G1 arrest and prolonged the latencies of AML mouse in vitro and in vivo.